Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3926896rdf:typepubmed:Citationlld:pubmed
pubmed-article:3926896lifeskim:mentionsumls-concept:C0029341lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:3926896lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:3926896pubmed:issue3lld:pubmed
pubmed-article:3926896pubmed:dateCreated1985-9-19lld:pubmed
pubmed-article:3926896pubmed:abstractTextThe in vitro T cell-dependent antibody response of human lymphocytes to influenza virus X31 was used to study the role of T cell-derived lymphokines in antigen-specific responses. Supernatant from cultures of phytohaemagglutinin-stimulated, pooled human tonsil cells (PHA-MLR) was capable of replacing T cells and inducing T-depleted tonsil cells to secrete influenza-specific antibody. The T cell-replacing activity of PHA-MLR supernatant co-purified with interleukin 2 (IL 2) on Ultrogel AcA54 gel filtration and reversed phase-high performance liquid chromatography. PHA-MLR supernatant and IL 2 also enhanced B cell proliferation induced by anti-mu or Staphylococcal aureus strain Cowan I (SAC). A murine monoclonal antibody directed against the human IL 2 receptor (Mab 2A3) was used to completely block the enhancement of influenza-specific antibody production mediated by PHA-MLR supernatant, purified IL 2, and recombinant human IL 2. Mab 2A3 did not affect the T-independent B cell proliferation induced by anti-mu or SAC, but abrogated the enhancing effect of the PHA-MLR supernatant and IL 2 in this culture system. Immunofluorescence studies failed to demonstrate binding of Mab 2A3 to B cells activated by the X31 influenza virus and IL 2, or by SAC. By using Mab 2A3 to mask out IL 2 effects in the influenza-specific culture system, no other B cell differentiating activities were revealed in supernatants from lymphocytic cultures stimulated with a variety of mitogens. Thus, our results indicate that the production of influenza-specific antibodies by T-depleted human lymphocyte cultures is absolutely dependent on the presence of both antigen and IL 2.lld:pubmed
pubmed-article:3926896pubmed:languageenglld:pubmed
pubmed-article:3926896pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3926896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3926896pubmed:statusMEDLINElld:pubmed
pubmed-article:3926896pubmed:monthSeplld:pubmed
pubmed-article:3926896pubmed:issn0022-1767lld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:BoothR JRJlld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:PrestidgeR...lld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:GillisSSlld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:TanP LPLlld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:DowerS KSKlld:pubmed
pubmed-article:3926896pubmed:authorpubmed-author:WatsonJ DJDlld:pubmed
pubmed-article:3926896pubmed:issnTypePrintlld:pubmed
pubmed-article:3926896pubmed:volume135lld:pubmed
pubmed-article:3926896pubmed:ownerNLMlld:pubmed
pubmed-article:3926896pubmed:authorsCompleteYlld:pubmed
pubmed-article:3926896pubmed:pagination2128-33lld:pubmed
pubmed-article:3926896pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:meshHeadingpubmed-meshheading:3926896-...lld:pubmed
pubmed-article:3926896pubmed:year1985lld:pubmed
pubmed-article:3926896pubmed:articleTitleInduction of antibody responses to influenza virus in human lymphocyte cultures. I. Role of interleukin 2.lld:pubmed
pubmed-article:3926896pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3926896pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3926896lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3926896lld:pubmed